2 Comments
Mar 21, 2023Liked by scott cunningham

Thanks Scott. Great stuff. Keep it going.

Expand full comment
author

Thanks Ronald! I've gotten some pretty good ones this year. I've got banked about ten more in the can, too, and a few more on deck in the ensuing weeks, including a new one with Alberto Abadie which I'm excited about. I posted a short interview I did with him early on of season one, but that was when I was really still trying to figure out the concept of the podcast. And that was largely just to help me on a substack I was writing regarding synth. This time I'm just going to be doing the more typical interview of "oral history of econ / personal stories of economists", and in the causal inference series. I also actually have two on psychedelic medicine, which I'm excited about. One with Mike Jay, an author on the history of medicine who wrote a book on Mescaline for Yale University Press that I thought was interesting, and Rick Strassman, a psychiatrist emeritus on faculty at University of New Mexico's medical school who was the very first person to successfully navigate the gauntlet of regulatory bureaucracy of both the FDA and DEA to study psychedelics effect on humans during what I typically just call the "post ban era". I'm not sure I'll do many more of those, but his story is I think interesting and while not about the oral history of economics itself, I think many economists will find it interesting because it's about things, tangentially, that they themselves have seen -- ambition, curiosity, grants, working on the frontier of things that maybe aren't interesting to colleagues, delayed appreciation, and mental health, not to mention relevant for those looking for new research opportunities as we, as a country, embark on a new phase of legal, above ground mainstreaming of "psychedelic medicine", which is happening now (two states, 15 cities, and imminent rescheduling by the DEA). I am enjoying this hobby of interviewing a lot.

Expand full comment